Importance of qEEG in Depression as a Diagnostic and Treatment Tool for qEEG Guided Neurotherapy

Tanju Surmeli, MD, BCIA-EEG
2-day Workshop
April 12 | April 13

Neurometric databases differential sensitivity to a number of developmental, neurological and psychiatric disorders has repeatedly been reported by numerous psychiatric groups. In Neurometric qEEG analysis, all qEEG variables are calculated as Z-scores which means -/+2 standard deviation for age is normal. The length of the standard deviation represents the severity of the neuropathology and abnormality. On the hypothesis that neurofeedback treatment will most benefit the patients who normalize the Z-score on their qEEG, case studies were presented illustrating that the successful application of neurometric analysis guided neurofeedback (NF) in patients with depression. Database-guided NF has been used successfully in numerous cases of ADHD, depression, and mTBI. Learn the fundamentals of qEEG findings in some psychiatric illnesses (Depression, vs Bipolar Disorder, Dementia, Personality disorders OCD, Schizophrenia, mTBI, and Substance Abuse) and be able to recognize characteristic qEEG neurometric analysis power patterns (absolute power, relative power, asymmetry, coherence) before neurofeedback treatment and during neurofeedback treatment. Develop a rationale intervention based on this assessment data which develops baseline qEEG guided NF treatment protocols for personalized medicine treatment model in depression.

Learning Objectives

To be able to use one of the non-medication treatments for Depression such as neurofeedback. If depression patients don’t get better with medication or other treatments, to learn more effective ways of treating depression. Learn how to use qeeg as a diagnostic tool.

About Dr. Tanju Surmeli

Dr Tanju Surmeli received his Medical Doctor degree from Dokuz Eylül University in Izmir, Turkey. Dr Surmeli completed the Global Clinical Scholars Research Training in Clinical Trials at Harvard, and completed a Research Fellowship in EEG and psychopharmacology at New York Medical College. He did his post-doctoral training in Family therapy at the Ackerman Institute for Family Therapy, worked at the Manic depression Foundation and Colombia-NYSPI under Prof. Ronald Fieve, and learned hypnosis at the Milton Ericson Hypnosis Institute. Dr Surmeli did his residency training in Psychiatry and Neurology at University of Connecticut/Institute of Living, Yale, and University of Texas, San Antonio. He is a board and ECFM certified psychiatrist. His associate professorship application is under reviewal by the Turkish Higher Education Board’s appointed jury for reviewal of works. In 2001, he founded the Healthy Living Polyclinic and is also the founder of the Biofeedback, Neurofeedback and QEEG/ERP use in Psychiatry Foundation. He is the only BCIAC-EEG certified psychiatrist in Turkey. He is the elected president of the International Quantitative Board of Electrophysiology and a former international board member of the International Society for Neurofeedback and Research in the US. He is also a member of the board of the Society of Applied Neuroscience in Norway. He has published about QEEG, Neurofeedback in Alzheimer’s Disease, Vasculer Dementia, Down Syndrome, Mental Disability, Obsessive Compulsive Disorder,Post Concussive Syndrome, Personality Disorders and Schizophrenia. He recently submitted a project to conduct a placebo-controlled neurofeedback study in Alzheimer’s to Harvard Medical School. He has authored book chapters for Elsevier about Evidence supporting neurofeedback for adult psychiatric disorders and Treatment of Thought Disorders. He has also authored the foreword for the Turkish version of Prof. Dr. Irvin Kirsch’s “The Emperor’s New Drugs: Exploding the Antidepressant Myth,” and his own book “The Healing Power of the Brain: the importance of Neurofeedback and QEEG in Psychiatry.”